DERMA SCIENCES, INC. (DSCI) [Rocket]

In millions, except per share items	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Traditional Wound Care	42.7	45.6	45.8	47.8	46.7
Advanced Wound Care	41.8	38.1	33.9	24.8	15.9
Other	9.2			6.6	5.7		2.4	2.7
Skin Care							0.7	0.8
Other							45.3	46.7
Total revenues	84.5	83.7	79.7	72.6	62.6	56.5	48.5	50.2
Revenue growth [+]	0.9%	5.1%	9.7%	16.0%	10.9%	16.4%	-3.3%	47.1%
Traditional Wound Care	-6.4%	-0.3%	-4.3%	2.4%
Advanced Wound Care	9.6%	12.3%	36.6%	55.9%
Other				14.3%			-10.8%	62.1%
Skin Care							-2.7%	-14.9%
Wound Care							-3.4%	53.8%
Cost of goods sold	51.7	53.6	50.3	47.5	45.2	39.9	33.5	35.3
Gross profit	32.7	30.1	29.4	25.1	17.4	16.5	15.1	14.9
Gross margin	38.8%	36.0%	36.9%	34.6%	27.8%	29.3%	31.0%	29.7%
Selling, general and administrative	51.4	50.8	41.9	32.5	21.2	17.9	15.1	17.2
Research and development	0.8	0.4		7.1	1.1	0.3	0.4	0.7
Other operating expenses					-1.0
EBITDA [+]				-11.2	-1.3	0.9		-0.1
EBITDA growth	-8.7%	86.4%	-13.1%	787.1%	-237.7%	-291.7%	458.7%	-288.1%
EBITDA margin	-19.6%	-21.6%	-12.2%	-15.4%	-2.0%	1.6%	-1.0%	-0.2%
Depreciation				1.0	1.0	0.9		1.4
EBITA	-16.5	-18.1	-9.7	-12.2	-2.3	0.0	-0.5	-1.5
EBITA margin	-19.6%	-21.6%	-12.2%	-16.8%	-3.6%	0.0%	-1.0%	-3.0%
Amortization of intangibles	3.0	3.1	2.8	2.3	1.6	1.7		1.4
EBIT [+]	-19.5	-21.2	-12.6	-14.5	-3.8	-1.7	-0.5	-2.9
EBIT growth	-7.9%	68.7%	-13.2%	278.8%	128.6%	250.1%	-83.8%	130.8%
EBIT margin	-23.1%	-25.3%	-15.8%	-19.9%	-6.1%	-3.0%	-1.0%	-5.9%
Non-recurring items [+]	2.5
Restructuring charges	2.5
Interest expense, net [+]					-0.3	0.6	0.8	0.9
Interest expense						0.6	0.8	0.9
Interest income					0.3
Other income (expense), net [+]	-0.6	0.2	0.2	0.0	-0.7	0.2	0.2	0.0
Gain (loss) on debt retirement					0.2	0.1
Other	0.6	-0.2	-0.2	0.0	0.0	0.3		0.0
Pre-tax income	-22.6	-21.0	-12.4	-14.4	-4.3	-2.0	-1.1	-3.9
Income taxes	-2.2	-0.2	0.2	-2.4	0.1	0.4	0.2	0.1
Tax rate	9.9%	0.7%		16.4%
Minority interest	-17.7	-18.9	-11.4
Net income	-38.1	-39.8	-24.0	-12.1	-4.3	-2.4	-1.3	-4.0
Net margin	-45.1%	-47.5%	-30.1%	-16.6%	-6.9%	-4.3%	-2.6%	-7.9%

Basic EPS [+]	($0.79)	($0.85)	($0.73)	($0.97)	($0.49)	($0.39)	($0.25)	($0.82)
Growth	-6.7%	15.4%	-24.0%	95.5%	27.9%	51.6%	-68.9%	853.1%
Diluted EPS [+]	($0.79)	($0.85)	($0.73)	($0.97)	($0.49)	($0.39)	($0.25)	($0.82)
Growth	-6.7%	15.4%	-24.0%	95.5%	27.9%	51.6%	-68.9%	853.1%

Shares outstanding (basic) [+]	25.7	24.6	17.1	12.5	8.8	6.3	5.0	4.8
Growth	4.7%	44.1%	36.6%	42.2%	38.6%	25.9%	4.3%	-81.8%
Shares outstanding (diluted) [+]	25.7	24.6	17.1	12.5	8.8	6.3	5.0	4.8
Growth	4.7%	44.1%	36.6%	42.2%	38.6%	25.9%	4.3%	-81.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.